Matches in Wikidata for { <http://www.wikidata.org/entity/Q87999985> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q87999985 description "2018 թվականին հրատարակված գիտական հոդված" @default.
- Q87999985 description "article scientifique (publié 2018)" @default.
- Q87999985 description "articolo scientifico (pubblicato il 2018)" @default.
- Q87999985 description "artigo científico (publicado na 2018)" @default.
- Q87999985 description "artikull shkencor i botuar më 01 janar 2018" @default.
- Q87999985 description "artículo científico publicado en 2018" @default.
- Q87999985 description "artículu científicu espublizáu en xineru de 2018" @default.
- Q87999985 description "im Januar 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q87999985 description "scientific article published on 01 January 2018" @default.
- Q87999985 description "wetenschappelijk artikel" @default.
- Q87999985 description "наукова стаття, опублікована 1 січня 2018" @default.
- Q87999985 description "научна статия" @default.
- Q87999985 name "Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients" @default.
- Q87999985 name "Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients" @default.
- Q87999985 name "Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients" @default.
- Q87999985 type Item @default.
- Q87999985 label "Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients" @default.
- Q87999985 label "Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients" @default.
- Q87999985 label "Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients" @default.
- Q87999985 prefLabel "Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients" @default.
- Q87999985 prefLabel "Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients" @default.
- Q87999985 prefLabel "Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients" @default.
- Q87999985 P1433 Q87999985-36DB42D9-E8DE-4F73-A2D9-4824C2EFD1FB @default.
- Q87999985 P1476 Q87999985-C2D9249F-0BAE-4391-83DA-8D43578AC72F @default.
- Q87999985 P2093 Q87999985-707BFCCE-7FC4-4898-990F-51BBFA3A8754 @default.
- Q87999985 P2093 Q87999985-80958A18-2A0F-4BE6-957B-76B013B979B8 @default.
- Q87999985 P2093 Q87999985-84E0BB45-A4B7-4C40-83EF-69EAA3FF98A0 @default.
- Q87999985 P2093 Q87999985-BFAD3F32-1555-433D-9A45-A44055165382 @default.
- Q87999985 P2093 Q87999985-E52AB608-9EE1-4945-A37A-B959160E47A1 @default.
- Q87999985 P304 Q87999985-9A8D7BBD-A349-4E9A-9E00-B25F6B3652FC @default.
- Q87999985 P31 Q87999985-73BE5FDE-0555-498D-898D-B790C656AD46 @default.
- Q87999985 P356 Q87999985-F0CC9C49-BDEA-4D94-BA18-944AE754822C @default.
- Q87999985 P433 Q87999985-ACD73F99-F08A-4F57-8C40-3A6C68CC80F1 @default.
- Q87999985 P478 Q87999985-9B7073C6-1749-41D2-B561-062A10580A2A @default.
- Q87999985 P577 Q87999985-3A37B659-8C45-4E80-B310-D82C5A2A28E5 @default.
- Q87999985 P698 Q87999985-AC2D9665-D7BD-4960-B4EB-E2C0D3972BF6 @default.
- Q87999985 P921 Q87999985-F0A901B5-7EDD-4D9A-90F3-17646E2CAC2A @default.
- Q87999985 P356 JCRT.JCRT_1175_16 @default.
- Q87999985 P698 29516985 @default.
- Q87999985 P1433 Q400140 @default.
- Q87999985 P1476 "Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients" @default.
- Q87999985 P2093 "Caixia Li" @default.
- Q87999985 P2093 "Fubo Xie" @default.
- Q87999985 P2093 "Kai Zhang" @default.
- Q87999985 P2093 "Wencheng Jian" @default.
- Q87999985 P2093 "Xiangyang Sun" @default.
- Q87999985 P304 "196-200" @default.
- Q87999985 P31 Q13442814 @default.
- Q87999985 P356 "10.4103/JCRT.JCRT_1175_16" @default.
- Q87999985 P433 "1" @default.
- Q87999985 P478 "14" @default.
- Q87999985 P577 "2018-01-01T00:00:00Z" @default.
- Q87999985 P698 "29516985" @default.
- Q87999985 P921 Q1148337 @default.